Skip to content

MiMedx Group MDXG Long-Term Debt

Long-Term Debt at other companies

IAR
Integra LifeSciencesIART
$1.75B+55.1%
Artivion logo
ArtivionAORT
$215.35M-31.5%
Solventum logo
SolventumSOLV
$5.08B-35.0%
Enovis logo
EnovisENOV
$1.29B-5.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$6.3B-4.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$37.53B-2.2%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's long-term debt?
MiMedx Group (MDXG) reported long-term debt of $16.09M in Q1 2026.
How has MiMedx Group's long-term debt changed year-over-year?
MiMedx Group's long-term debt decreased by 8.2% year-over-year, from $17.53M to $16.09M.
What is the long-term trend for MiMedx Group's long-term debt?
Over 5 years (2020 to 2025), MiMedx Group's long-term debt has grown at a -19.2% compound annual growth rate (CAGR), from $47.7M to $16.47M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.